Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
149.22
+6.28 (4.39%)
At close: Jun 26, 2026, 4:00 PM EDT
150.00
+0.78 (0.52%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Guardant Health Stock Forecast
Stock Price Forecast
The 21 analysts with 12-month price forecasts for Guardant Health stock have an average target of 144.76, with a low estimate of 125 and a high estimate of 185. The average target predicts a decrease of -2.99% from the current stock price of 149.22.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Guardant Health stock from 25 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 17 | 16 | 16 | 16 | 19 |
| Buy | 5 | 5 | 5 | 4 | 4 | 5 |
| Hold | 1 | 2 | 2 | 2 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 24 | 23 | 22 | 22 | 25 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bernstein | Bernstein | Buy Reiterates $175 | Buy | Reiterates | $175 | +17.28% | Jun 26, 2026 |
| Barclays | Barclays | Buy Reiterates $120 → $150 | Buy | Reiterates | $120 → $150 | +0.52% | Jun 24, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $125 | Buy | Maintains | $125 | -16.23% | Jun 17, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $185 | Buy | Initiates | $185 | +23.98% | Jun 11, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $135 → $175 | Buy | Maintains | $135 → $175 | +17.28% | Jun 8, 2026 |
Financial Forecast
Revenue This Year
1.31B
from 982.02M
Increased by 33.84%
Revenue Next Year
1.71B
from 1.31B
Increased by 29.76%
EPS This Year
-1.40
from -1.82
EPS Next Year
-0.39
from -1.40
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.3B | 1.9B | |
| Avg | 1.3B | 1.7B | |
| Low | 1.3B | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 34.5% | 45.2% | |
| Avg | 33.8% | 29.8% | |
| Low | 32.7% | 23.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.14 | 1.10 | |
| Avg | -1.40 | -0.39 | |
| Low | -1.76 | -1.05 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.